HedgeChatter

  • Home /
  • Tag Archives

IMMU

8:31 am Immunomedics reported results from preclinical studies on the Co’s two investigational SN-38-containing antibody drug conjugates (ADCs), IMMU-130 and IMMU-132, that demonstrated a high therapeutic index for both agents.

moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

April 9, 2014 Bystocknews , Comments Off on 8:31 am Immunomedics reported results from preclinical studies on the Co’s two investigational SN-38-containing antibody drug conjugates (ADCs), IMMU-130 and IMMU-132, that demonstrated a high therapeutic index for both agents. read more

11:01 am Immunomedics announces that 5 patients reported a partial response as their best response in the Company’s ongoing Phase I/II clinical trial of IMMU-132 in patients with solid cancers

moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

April 8, 2014 Bystocknews , Comments Off on 11:01 am Immunomedics announces that 5 patients reported a partial response as their best response in the Company’s ongoing Phase I/II clinical trial of IMMU-132 in patients with solid cancers read more

EQUITY ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Class Action Deadline — IMMU

[GlobeNewswire] – NEW YORK — The Rosen Law Firm, P.A. reminds purchasers of the common stock of Immunomedics, Inc. between May 9, 2013 and October 9, 2013 of the important April 28, 2014 lead plaintiff deadline in the … moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring […]

March 27, 2014 Bystocknews , Comments Off on EQUITY ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Class Action Deadline — IMMU read more

IMMUNOMEDICS INC Financials

moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

March 22, 2014 Bystocknews , Comments Off on IMMUNOMEDICS INC Financials read more

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact Brower Piven Before the April 28, 2014 Lead Plaintiff Deadline — IMMU

[GlobeNewswire] – STEVENSON, Md. — Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers … moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here […]

March 20, 2014 Bystocknews , Comments Off on SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact Brower Piven Before the April 28, 2014 Lead Plaintiff Deadline — IMMU read more

Girard Gibbs Announces Class Action Lawsuit on Behalf of Investors of Immunomedics, Inc.

[Business Wire] – Girard Gibbs LLP announces that a class action lawsuit has been filed on behalf of purchasers of Immunomedics, Inc. common stock between May 9, 2013 and October 9, 2 moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here to view […]

February 28, 2014 Bystocknews , Comments Off on Girard Gibbs Announces Class Action Lawsuit on Behalf of Investors of Immunomedics, Inc. read more

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics, Inc. – IMMU

[PR Newswire] – NEW YORK, Feb. 28, 2014 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Immunomedics, Inc. (Immunomedics or the Company) (IMMU). Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click […]

February 28, 2014 Bystocknews , Comments Off on SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics, Inc. – IMMU read more

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Involving IMMUNOMEDICS, INC. and Its Board of Directors and a Deadline of April 28, 2014 to Seek a Lead Plaintiff Position — IMMU

[GlobeNewswire] – NEW YORK — Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Immunomedics, Inc. (Immunomedics … moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here […]

February 27, 2014 Bystocknews , Comments Off on SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Involving IMMUNOMEDICS, INC. and Its Board of Directors and a Deadline of April 28, 2014 to Seek a Lead Plaintiff Position — IMMU read more

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Involving IMMUNOMEDICS, INC. and Its Board of Directors and a Deadline of April 28, 2014 to Seek a Lead Plaintiff Position — IMMU

[GlobeNewswire] – NEW YORK — Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Immunomedics, Inc. (Immunomedics … moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click here […]

February 27, 2014 Bystocknews , Comments Off on SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Involving IMMUNOMEDICS, INC. and Its Board of Directors and a Deadline of April 28, 2014 to Seek a Lead Plaintiff Position — IMMU read more

Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Immunomedics, Inc.

[Business Wire] – Robbins Geller Rudman & Dowd LLP today announced that a class action has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. moreView todays social media effects on IMMUView the latest stocks trending across Twitter. Click to view dashboardSee who Immunomedics is hiring next, click […]

February 27, 2014 Bystocknews , Comments Off on Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Immunomedics, Inc. read more